Atlas Point Media

Health Policy Podcast

News EN ↓ 63 episodes

The Health Policy Podcast explores how healthcare policy decisions impact patients, providers, costs, and innovation across the U.S. healthcare system. Through interviews with physicians, policy experts, researchers, and industry leaders, the podcast examines the real-world effects of laws, regulations, and market forces shaping healthcare today.

Be sure to visit the podcast's website and support the creator: sites.libsyn.com

Author

Atlas Point Media

Category

News

Podcast website

sites.libsyn.com

Latest episode

Nov 17, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Mapping Medical Freedom: Key Insights from the 2026 Health Freedom Index 17.11.2026

In this episode of the Health Policy Podcast, host Brian Hyde sits down with Jared Rhoads, founder and executive director of the Center for Modern Health, to unpack the findings of the 2026 Health Freedom Index. Jointly produced with the Knee Regulatory Research Center, the report evaluates all 50 states and Washington, D.C., across 54 policy variables grouped into professional, institutional, pat...

The Patient as Single Payer: Dr. Deane Waldman on Reforming Medicaid and Halting Healthcare Fraud 10.11.2026

In this episode of the Health Policy Podcast, host Brian Hyde sits down with pediatric cardiologist and healthcare policy analyst Dr. Dean Waldman, Chairman of the Board at the Empower Patients Initiative and author of "Become an Empowered Patient." Dr. Waldman critiques post-pandemic Medicaid expansions, explains how third-party payment systems facilitate large-scale fraud and administrative wast...

AI in Healthcare: Separating Hype from Hope with Mark P. Mills 05.11.2026

In this episode of the Health Policy Podcast, host Brian Hyde speaks with Mark P. Mills of the National Center for Energy Analytics about the real-world applications and transformative potential of Artificial Intelligence in healthcare. Mills cuts through the hype, detailing how AI acts as an incredibly powerful research assistant, significantly improving diagnostics, and most notably, offers a 't...

Empowering Patients: Reclaiming Control Over Healthcare 03.11.2026

In this episode of the Health Policy Podcast, Dr. Dean Waldman discusses the systemic issues plaguing the U.S. healthcare system, particularly how consumers lost control over spending and its detrimental effects on both patients and medical professionals. He traces the roots of this problem back to the post-WWII era and the rise of employer-sponsored health benefits, advocating for a return of fin...

Breaking down barriers to treatment-resistant depression care with Dr. Michelle Cochran 27.10.2026

For patients with treatment-resistant depression, finding a therapy that works is only half the battle. Insurance coverage, prior authorization and step therapy rules can keep evidence-based care out of reach. In this episode, we speak with Michelle Cochran, MD, a board-certified psychiatrist, Distinguished Fellow of the American Psychiatric Association, and Fellow of the Clinical TMS Society. She...

Moneyball Healthcare: How E-Consults are Revolutionizing Patient Care 27.10.2026

In this episode, Brian Hyde interviews John E. Harrison, CEO of Gesundheit, an e-consult platform transforming healthcare delivery. Harrison explains how Gesundheit adapts the VA's successful e-consult model, which achieved 40% cost savings and eliminated 60% of physical specialist visits, to the fragmented U.S. healthcare system. He draws parallels to the "Moneyball" concept, advocating for a str...

Untangling Healthcare Costs: The Role of Government and Competition with Dr. Vance Ginn 22.10.2026

In this episode of the Health Policy Podcast, host Brian Hyde speaks with Dr. Vance Ginn, staff economist for Americans for Tax Reform and president of Ginn Economic Consulting. Dr. Ginn clarifies that while many states target Pharmacy Benefit Managers (PBMs) to lower prescription costs, this approach often "misses the forest for the trees." He argues that the majority of healthcare expenditures,...

The USF "Tech Tax": A Threat to Digital Health Innovation 20.10.2026

The Universal Service Fund (USF), originally designed to increase connectivity, has evolved into an $8 billion annual expenditure, resulting in a nearly 40% increase in phone bills for American consumers. With calls to expand USF contributions to include tech services and broadband providers, there is a growing concern that such a "tech tax" would stifle innovation in digital health therapeutics,...

Washington's PFAS and Cookware Rules: Rising Costs and Affordability Concerns 15.10.2026

Jan Himebaugh, president and CEO of the Washington Retail Association, discusses Washington state's approach to regulating chemicals in cookware, including PFAS and lead. She shares retailers' concerns about compliance costs, product availability, and affordability, arguing for measurable standards and greater alignment with federal requirements.

Navigating the ACA: Why Silver Plans Now Cost More Than Gold 13.10.2026

Tony LoSasso, a professor of health economics at the University of Wisconsin-Madison, discusses the unexpected phenomenon of silver plans costing more than gold plans in many Affordable Care Act marketplaces. He explains that this is a result of a tangled policy design, specifically the federal government ceasing direct cost-sharing subsidies in 2017. Insurers responded by inflating silver plan pr...

The Preventable Peptide Crisis: Navigating GLP-1s and the Gray Market 08.10.2026

In this episode of the Health Policy Podcast, host Brian Hyde speaks with Peter Pitts, former FDA Associate Commissioner and President of the Center for Medicine in the Public Interest. They discuss the growing popularity of GLP-1 weight loss drugs and the critical issues surrounding their use. Pitts emphasizes that while GLP-1s can be effective, they are not a "magic pill" and should be used unde...

Beyond Politics: A New Era in Global Health Strategy 06.10.2026

Dr. Alma Golden, pediatrician and former Assistant Administrator for Global Health at USAID, discusses the evolution of global health strategy on the Health Policy Podcast. She highlights a shift from previous approaches—often characterized by funding tied to specific mandates through NGOs—to the "America First" strategy's emphasis on bilateral agreements, country-led priorities, and whole-person...

Drug Prices: The Real Cost of Government Intervention 01.10.2026

In this episode of the Health Policy Podcast, host Brian Hyde speaks with Eric Moss, Director of Health and Science Policy at Citizens Against Government Waste. They delve into the complex landscape of prescription drug pricing in America, discussing how federal programs like 340B and provisions within the Inflation Reduction Act (IRA) have impacted costs and access. Moss reveals that despite init...

Taxpayer Advocate Pete Sepp: Washington State's Cookware Rules Go "Overboard" 29.09.2026

National Taxpayers Union President Pete Sepp argues that Washington State's regulation of PTFE, the coating used in nonstick cookware, goes too far by treating it the same as the broader PFAS "forever chemicals" family. Sepp points out that California Gov. Gavin Newsom vetoed a similar cookware bill, citing affordability and lost consumer choice, and says Washington's approach would drive up costs...

The GLP-1 Bridge Program: Price Fixing vs. Free Market Healthcare 24.09.2026

In this episode of the Health Policy Podcast, host Brian Hyde speaks with Jay Goldberg, North American Affairs Manager at the Consumer Choice Center, about the GLP-1 Bridge Program. While the program aims to make weight loss drugs like GLP-1s more affordable for Medicare and Medicaid recipients, Goldberg argues it exemplifies government price fixing. He explains how artificially lowering drug pric...

As Washington State Regulates Nonstick Cookware, Toxicologist Says Fear Outpaces Evidence 22.09.2026

Washington State requires manufacturers to report PFAS levels in nonstick cookware by January 31, 2027—a reporting mandate that falls short of an outright ban after industry pushback. Environmental toxicologist Susan Goldhaber challenges the scientific basis for such restrictions, arguing that regulations lump together 7 million compounds under one umbrella without distinguishing toxic from benign...

Breaking the Hospital Monopoly: Why Competition is Illegal in Healthcare 17.09.2026

Jared Rhoads, founder of the Center for Modern Health, joins the show to discuss how government interventions and third-party payment systems distort hospital pricing. He explains the hidden dangers of "cross-subsidization"—where profitable departments prop up money-losers—and how Certificate of Need (CON) laws are used to stifle competition and protect established healthcare monopolies.  

Washington State's Nonstick Cookware Rule: What It Means for Your Kitchen 15.09.2026

Washington state is pressing ahead with a rule requiring cookware makers to disclose PFAS use in nonstick pans — even after California Gov. Gavin Newsom vetoed a similar ban over affordability concerns. David Clement, policy director at the Consumer Choice Center, joins the podcast to explain what PFAS actually are, why Washington's disclosure requirement could function as a backdoor ban, and what...

Untangling 340B: Medicare's Proposed Payment Cuts and the Future of Healthcare 10.09.2026

In this episode of the Health Policy Podcast, host Brian Hyde speaks with Sydney Halleman, senior editor for Healthcare Dive, senior editor for Healthcare Dive, about the intricacies of Medicare's proposed rules impacting the 340B drug pricing program, site-neutral payments, and price transparency. Halleman explains the 340B program's origins, its expansion, and the Trump administration's efforts...

Understanding Treatment-Resistant Depression: A Conversation with Dr. Augustus John Rush 08.09.2026

In this episode of the Health Policy Podcast, host Brian Hyde welcomes Dr. Augustus John Rush, an internationally renowned psychiatrist and leading expert on depression and treatment-resistant depression (TRD). Dr. Rush shares insights from his five decades of clinical research and patient care, emphasizing that "the depressions" vary widely, from mild, time-limited episodes to devastating, life-s...

Healthcare's Grip on Midterm Elections: A Survey of Voter Frustration 03.09.2026

  Joel White, President of the Council for Affordable Health Coverage, discusses the surprising influence of healthcare costs on upcoming midterm elections, particularly in nine key Senate battleground states. A recent survey reveals widespread voter frustration across party lines due to unaffordable healthcare, making it a top-tier issue, even surpassing war and immigration in importance for many...

Elijah Stacy on Right to Try Legislation and Individualized Medicine 01.09.2026

Elijah Stacy, an advocate for Right to Try legislation, discusses his personal journey with Duchenne muscular dystrophy and his fight for individualized treatments. He explains the devastating effects of DMD, a fatal muscle-wasting disease, and shares his experience starting a nonprofit, writing a book, and consulting for biotech companies. Stacy passionately argues for patient freedom in accessin...

Psychedelics in Mental Health: From Clinical Trials to State Lines 27.08.2026

Jennifer Cutler, partner at DCI Group, joins Brian Hyde to discuss the evolving landscape of mental health policy, specifically focusing on the role of psychedelics. They delve into the FDA approval process, the critical need for states to prepare their regulatory frameworks for patient access, and common misconceptions surrounding psychedelic-assisted therapy. Cutler highlights the bipartisan sup...

Rethinking Section 6001: The Case for Physician-Owned Hospitals 25.08.2026

Reinier Schuur, a policy analyst at the Center for Modern Health, explains the complexities and impact of Section 6001 of the Affordable Care Act (ACA), particularly concerning physician-owned hospitals. This section, enacted in 2010 due to lobbying by the American Hospital Association, prohibits new physician-owned hospitals from receiving Medicare reimbursement, effectively creating a significan...

Unlocking the Potential of Generic Drugs: A Conversation with Chris Snyder on Drug Repurposing and Market Incentives 20.08.2026

In this episode, Brian Hyde interviews Chris Snyder, a Hyatt Professor of Economics at Dartmouth College and co-director of the Market Shaping Accelerator. They delve into the concept of repurposed drugs, particularly generics, and the economic disincentives that lead to missed opportunities for new treatments. Snyder explains how the Market Shaping Accelerator uses "pull funding" to incentivize i...

Listen to the Health Policy Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.